Reikvam H - Search Results

1

Hemsing AL, Hovland R, Tsykunova G, Reikvam H. Hemsing AL, et al. Among authors: reikvam h. Expert Rev Hematol. 2019 Nov;12(11):947-958. doi: 10.1080/17474086.2019.1657400. Epub 2019 Sep 26. Expert Rev Hematol. 2019. PMID: 31422708 Review.

2

Targeted therapy in acute myeloid leukaemia: current status and future directions.

Stapnes C, Gjertsen BT, Reikvam H, Bruserud Ø. Stapnes C, et al. Among authors: reikvam h. Expert Opin Investig Drugs. 2009 Apr;18(4):433-55. doi: 10.1517/14728220902787628. Expert Opin Investig Drugs. 2009. PMID: 19335274 Review.

3

Targeting the angiopoietin (Ang)/Tie-2 pathway in the crosstalk between acute myeloid leukaemia and endothelial cells: studies of Tie-2 blocking antibodies, exogenous Ang-2 and inhibition of constitutive agonistic Ang-1 release.

Reikvam H, Hatfield KJ, Lassalle P, Kittang AO, Ersvaer E, Bruserud Ø. Reikvam H, et al. Expert Opin Investig Drugs. 2010 Feb;19(2):169-83. doi: 10.1517/13543780903485659. Expert Opin Investig Drugs. 2010. PMID: 20050812

4

Nuclear factor-kappaB signaling: a contributor in leukemogenesis and a target for pharmacological intervention in human acute myelogenous leukemia.

Reikvam H, Olsnes AM, Gjertsen BT, Ersvar E, Bruserud Ø. Reikvam H, et al. Crit Rev Oncog. 2009;15(1-2):1-41. doi: 10.1615/critrevoncog.v15.i1-2.10. Crit Rev Oncog. 2009. PMID: 20136626 Review.

5

The chemokine network in acute myelogenous leukemia: molecular mechanisms involved in leukemogenesis and therapeutic implications.

Kittang AO, Hatfield K, Sand K, Reikvam H, Bruserud Ø. Kittang AO, et al. Among authors: reikvam h. Curr Top Microbiol Immunol. 2010;341:149-72. doi: 10.1007/82_2010_25. Curr Top Microbiol Immunol. 2010. PMID: 20376612 Review.

6

Therapeutic targeting of NF-κB in myelodysplastic syndromes and acute myeloid leukaemia - the biological heterogeneity.

Bruserud Ø, Reikvam H. Bruserud Ø, et al. Among authors: reikvam h. Expert Opin Ther Targets. 2010 Nov;14(11):1139-42. doi: 10.1517/14728222.2010.525021. Expert Opin Ther Targets. 2010. PMID: 20942744

7

The crosstalk between the matrix metalloprotease system and the chemokine network in acute myeloid leukemia.

Hatfield KJ, Reikvam H, Bruserud Ø. Hatfield KJ, et al. Among authors: reikvam h. Curr Med Chem. 2010;17(36):4448-61. doi: 10.2174/092986710794183033. Curr Med Chem. 2010. PMID: 21062258 Review.

8

Acute myeloid leukemia with the t(8;21) translocation: clinical consequences and biological implications.

Reikvam H, Hatfield KJ, Kittang AO, Hovland R, Bruserud Ø. Reikvam H, et al. J Biomed Biotechnol. 2011;2011:104631. doi: 10.1155/2011/104631. Epub 2011 May 3. J Biomed Biotechnol. 2011. PMID: 21629739 Free PMC article.

9

The surface molecule signature of primary human acute myeloid leukemia (AML) cells is highly associated with NPM1 mutation status.

Tsykunova G, Reikvam H, Hovland R, Bruserud Ø. Tsykunova G, et al. Among authors: reikvam h. Leukemia. 2012 Mar;26(3):557-9. doi: 10.1038/leu.2011.243. Epub 2011 Sep 9. Leukemia. 2012. PMID: 21904378 No abstract available.

10

Expression profile of heat shock proteins in acute myeloid leukaemia patients reveals a distinct signature strongly associated with FLT3 mutation status--consequences and potentials for pharmacological intervention.

Reikvam H, Hatfield KJ, Ersvaer E, Hovland R, Skavland J, Gjertsen BT, Petersen K, Bruserud O. Reikvam H, et al. Br J Haematol. 2012 Feb;156(4):468-80. doi: 10.1111/j.1365-2141.2011.08960.x. Epub 2011 Dec 13. Br J Haematol. 2012. PMID: 22150087 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

182 results

Search Page